Vulvar vestibulitis syndrome (vestibulitis), the most common type of chronic vulvovaginal pain, impairs the psychologic, physical, and reproductive health of approximately 10% of women at some point in their lives. Research on the pathophysiology of vestibulitis suggests abnormalities in 3 interdependent systems: vestibular mucosa, pelvic floor muscles, and central nervous system pain regulatory pathways. To date, causes and relative contributions of these abnormalities to the development and maintenance of vestibulitis remain poorly understood. Research consistently supports the conceptualization of vestibulitis as a chronic pain disorder-akin to fibromyalgia, irritable bowel disorder, and temporomandibular disorder (TMD)-that is far more complex than vestibular hypersensitivity alone. Nevertheless, the clinical diagnosis of vestibulitis continues to rely on subjective report of pain during intercourse and vestibular sensitivity on clinical examination after exclusion of other gynecologic disorders. We propose that current diagnostic criteria, which are based on highly subjective patient and clinician measures, are not sufficient to describe and properly classify the heterogeneous clinical presentations of this disorder. To inform clinical care or research, we must be able to objectively characterize women with vestibulitis. This narrative review critically appraises current conceptualization of vestibulitis and presents a context for studying vestibulitis as a chronic pain disorder, emphasizing the need for objective assessment of clinical features.
OVERVIEW
Although many women suffer in silence without seeking care and many go undiagnosed after seeking care, an estimated 200,000 women who receive a diagnosis of vestibulitis seek care each year in specialty clinics in the United States (1, 2) . Little is known about the etiology of vestibulitis, although it is thought to result from an exaggerated inflammatory response of the vulvar mucosa (vestibule) to injury. Clinical diagnosis remains one of exclusion. Before treatment for vestibulitis, patients have seen an average of 3 physicians (3) and had 5 years of pain (4, 5) . Vestibulitis is clinically defined by 3 subjective signs and symptoms: 1) entry dyspareunia; 2) tenderness to light touch (eg, cotton swab palpation) on the vestibule; and 3) presence of erythema (6) (7) (8) . Treatment options continue to be empiric and of variable efficacy, with biofeedback and surgical resection being the 2 most commonly used modalities (9) .
Vestibulitis, a functional versus organic disorder, is controversial. Proponents of vestibulitis as predominantly an organic disorder cite well-documented genetic differences in proinflammatory tendencies of the vestibular mucosa (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . In this model, commonly mentioned psychologic abnormalities and pelvic muscle dysfunction (spasm and difficulty with relaxation) are thought to result from a chronically inflamed and painful vestibular mucosa that causes reflexive guarding (20) (21) (22) (23) (24) (25) . On the other hand, others suggest that vestibulitis is a functional disorder. In this alternative model, psychosexual dysfunction is the antecedent to the development of vestibulitis. In support of this theory is the well-documented success of treatment with biofeedback or cognitive behavioral therapy (26) (27) (28) . Neither theory sufficiently explains what we observe in clinical practice: a range of vestibulitis patients, those in whom central nervous system (CNS) dysfunction is more predominant and others in whom mucosal sensitivity is primary. That is, some women report improvement in pain only after interventions specific to pelvic floor muscles and psychosexual function, others report improvement only after interventions directed at decreasing sensitivity of the vestibular mucosa, whereas the majority respond to combination therapy (29) (30) (31) (32) .
We speculate that the proinflammatory tendencies of the mucosa may, in fact, be a "risk marker" for the development of vestibulitis, that is, a necessary component of the clinical syndrome that leads to symptoms only in the context of a greater dysfunction (eg, pelvic floor dyssynergia secondary to central dysregulation). Our theory is that vestibulitis is a group of conditions characterized by varying degrees of pain and dysfunction in the mucosa, underlying musculature, and associated dysfunction in pain-regulatory systems (Fig. 1) . The clinical manifestations of vestibulitis may result from the convergence of a variety of pathophysiological mechanisms, including a predisposition of the mucosa toward heightened inflammatory response, pelvic muscle dysfunction, previous trauma (eg, childbirth, pudendal nerve injury, vaginitis), intrinsic CNS dysregulation, and modulation by psychologic traits.
This review appraises current literature in the pathophysiology of vestibulitis as it relates to peripheral (vestibular mucosa and pelvic floor muscles), central, and psychosocial factors in the manifestation of vestibulitis. The impetus behind this work is based on 2 fundamental principles: 1) conditions yielding persistent state of pain are too complex to be adequately diagnosed using a single axis (eg, anatomic location), and 2) concomitant assessment of biologic (peripheral and CNS) and psychologic (CNS) factors is necessary to identify subgroups with important pathophysiological differences (33, 34) . At the conclusion, we review the clinical implications of these observations and future directions for investigation of vestibulitis as a multidimensional pain disorder.
Is Vestibulitis a Disease of the Vestibular Mucosa?
Mucosal inflammation plays a central role in the clinical manifestations of vestibulitis (35) (36) (37) (38) (39) . Histologic and biomolecular analyses of vestibular mucosa among women with vestibulitis demonstrate distinct alterations in biochemical and neuronal composition (15) (16) (17) (18) (19) (40) (41) (42) . In comparison to women without pain, women with vestibulitis tend to express genetic variants that result in more potent proinflammatory substances (eg, IL-1␤, TNF-␣) (18) and less potent antiinflammatory counterparts (eg, IL-1, RA) (15, 19) . Persistent inflammation is the natural consequence of this imbalance between the proinflammatory and antiinflammatory arms of the immune system (12) .
Chronic inflammation results in proliferation of nociceptive nerve fibers (c-fibers) with altered receptor expression (41) . Sustained inflammatory response in the vulvar mucosa promotes both neuronal proliferation and persistent elevation of proinflammatory substances (43) (44) (45) (46) . This, in turn, lowers the sensory threshold of vestibular mucosa. In this setting, a normally imperceptible and painless stimulus is felt as painful among women with vestibulitis (allodynia) (38, 44) . Consequently, even light touch can result in exaggerated release of proinflammatory substances by the sensitized nerve fibers. These proinflammatory substances, in turn, activate inflammatory cells (eg, neuroendocrine cells and mast cells) to release more proinflammatory substances. This self-perpetuating process of inflammation (neurogenic inflammation) is thought to play a key role in maintenance of the local inflammation in vestibulitis (12, 20) .
Inability to break this self-perpetuating cycle of inflammation can lead to changes in the CNS such that patients experience sensory and motor abnormalities at regions (eg, arm, deltoid) remote from the original site of inflammation. This phenomenon is known as "central sensitization" (47) (48) (49) . Compared with women with no genital pain, women with vestibulitis have higher sensitivity to experimental pain stimuli at the nongenital regions. Central sensitization as described here is offered as the explanatory model. However, heightened sensitivity to nonpainful stimuli may occur independently and precede the development of chronic pain conditions such as vestibulitis (50). For example, harboring a less potent genetic variant of catecholamine-O-methyltransferase (COMT), an enzyme involved in catecholamine metabolism, is shown to be a risk factor for developing chronic myofascial pain disorder (eg, temporomandibular dysfunction); higher pain sensitivity to experimental pain is also observed among carriers of this less potent variant of COMT (50) .
Is Vestibulitis a Disease of the Pelvic Floor Muscle?
Pelvic floor muscle dysfunction of varying severity is commonly observed in women with vestibulitis. Treatments targeting physical (ie, biofeedback) and volitional control (ie, cognitive behavior therapy) of pelvic muscle contraction are common modalities in management of vestibulitis (9, 51) . One of the few randomized treatment trials for vestibulitis assessed the efficacy of 3 commonly used approaches for the treatment of vestibulitis: biofeedback, cognitivebehavioral therapy, and vestibulectomy on a sample of 78 women. Across the 3 arms, the baseline pain was 5.45 to 6.34 on a Likert scale of zero (no pain) to 10 (worse imaginable pain), which decreased to 1.9 to 4.42 at 6-month follow up (P Ͻ .01) (9) with no meaningful difference across groups.
The importance of pelvic floor muscle dysfunction in women with vestibulitis is widely acknowledged (21) . Most theories assume muscle dysfunction is secondary to chronic inflammation of the mucosa and, thus, reactive in nature (20) (21) (22) 52) . Some experts have postulated that skin disturbance in vestibulitis destabilizes the pelvic floor muscles, resulting in high resting tone and poor voluntary control (29) (30) (31) (32) . Others have viewed it as a reflexive phenomenon secondary to ongoing pain with attempted intercourse, similar to involuntary muscle "splinting" seen in the setting of acute musculoskeletal pain (21, 22) (53) .
Temporomandibular disorder (TMD) offers a model for muscle dysregulation as a primary process. Individuals with TMD have dysfunction in contraction and relaxation of the facial muscles that is associated with chronic orofacial pain (54) . TMD muscle dysfunction has been traced to an imbalance between central inhibitory and excitatory pathways. The net result is loss of adequate inhibition from the CNS to the involved muscles. This disinhibition of motor signal is thought to cause some of the clinical manifestations (clenching, difficulty with voluntary jaw opening) in women with TMD. In this case, primary abnormalities in muscle function are intimately associated with the development of pain. Such dysfunction in inhibitory pathways is also seen in association with another syndromatic pain disorder (eg, fibromyalgia). Not surprisingly, there is a known comorbidity between fibromyalgia and TMD (55, 56) . In fact, our own data support a similarly high comorbidity between TMD and vestibulitis. Seventy-eight percent of women with vestibulitis recently studied in our clinic were found to have concomitant diagnosis of TMD: clinical (40%) and subclinical (38%) (submitted for publication).
Alternatively, pelvic muscle dysfunction may be the consequence of chronic inflammation in the overlying vestibular mucosa. An inflammatory insult of the mucosa may initiate hypersensitivity (hyperalgesia) in the underlying musculature (57) . In animal models, as well as in human models, pain fibers (C-fibers and A-␤ fibers) that are sensitized by mucosal inflammation initiate, through polysynaptic spinal processes, hypersensitivity and contraction of the underlying musculature. Further sensitization of the muscle pain receptors may in turn, through a process of central sensitization, reduce sensory pain thresholds, resulting in a "vicious cycle" of inflammation and additional muscle contraction (53, 58) .
In summary, the pelvic floor muscle dysfunction commonly documented in women with vestibulitis, although clinically similar, could, in fact, be driven by distinctly different pathophysiological processes.
Does a State of Pain Amplification (Hypersensitivity in Nongenital Sites) Precede or Follow the Development of Vestibulitis?
Women with vestibulitis have measurable differences in sensory pain thresholds, a centrally regulated trait. A substantial proportion of women with vestibulitis shows hypersensitivity to several categories of pain (tactile, thermal, and pressure) at nongenital sites (25, 48, (59) (60) (61) . The thermal pain threshold for women with vestibulitis (42.2 Ϯ 2.5°C) is significantly lower than pain-free comparison groups (43.6 Ϯ 1.9°C) (P ϭ .006) (59) . Similarly, high sensitivity to pressure pain in the upper thighs (P ϭ .004) and deltoids (P Ͻ .05) is reported in this population (25) . Collectively, these observations point to an abnormal state of pain amplification among women with vestibulitis. However, the relative contribution of a state of pain amplification in initiation and maintenance of vestibulitis is poorly understood. Some investigators attribute this pain sensitivity to chronicity of pain in vestibulitis (central sensitization) (25, 62) , whereas others view it as a reflection of inherent dysfunction in pain-regulatory mechanisms (61, 63) . Over the past 3 years, a growing body of literature suggests that an inherent biologic abnormality in pain processing (a state of pain amplification) may be present in some women with vestibulitis (25, 47, 48, (59) (60) (61) (62) 64) .
Subgroups of women with vestibulitis differ along the continuum of extragenital pain sensitivity (60) . Women with vestibulitis are clinically divided into 2 subgroups: primary (women who have never had comfortable intercourse) and secondary (women who had no history of pain or dyspareunia until later into adult life). Women with primary onset of vestibulitis have greater pain sensitivity to thermal pain (P ϭ .019) despite reports of intercourse-related pain that are similar to women with secondary onset of vestibulitis (60) . These central regulatory differences suggest differences in underlying pathophysiological mechanisms (60) . Women with secondary vestibulitis may experience a local disease (ie, peripheral process), whereas those with primary onset may have dysfunction in pain-regulatory mechanisms in addition to the local vestibular and muscle pain. A onedimensional clinical classification schema based on the history of the onset of pain (primary vs secondary) is unlikely to explain the varying contributions of central and peripheral factors. Nevertheless, the ability to see such differences using this crude classification emphasizes the magnitude of heterogeneity in this population. The involvement of central painregulatory mechanisms may help explain observed differences in clinical severity and treatment outcomes in subgroups of women with this condition (60) . Poor treatment outcomes among women with extragenital pain sensitivity (marker for central dysregulation) (61) emphasize the need for a comprehensive multidimensional assessment of vestibulitis as a pain disorder.
Is Vestibulitis a Psychologic Disorder?
Specific psychologic traits may precede or be modified by chronic pain disorders. Little empiric attention has been given to the role of psychologic distress in vestibulitis with competing conceptualizations of the condition as either functional or organic (65) . Surprisingly, evidence does not suggest that histories of abuse or assault are more prevalent in patients with vestibulitis (66) (67) (68) (69) (70) . In fact, our own research team found that patients with vestibulitis tend to report less trauma and abuse than other populations of women in our chronic pelvic pain clinic (Leserman, American Journal of Obstetrics and Gynecology, in press). Nonetheless, anxiety, depression (65, (71) (72) (73) (74) (75) (76) , and somatization (tendency to report a higher frequency of bodily complaints) are commonly observed psychologic features among women with vestibulitis (25, 70, 75, 77) . Granot and Lavee found more trait anxiety (standard difference [d] ϭ 0.65, P Ͻ .01) and somatization (d ϭ 0.84, P Ͻ .01) among women with vestibulitis compared with a vestibulitis-free comparison group (63) .
Some investigators view vestibulitis as primarily a psychologic disorder (73, 78) , whereas others view psychologic dysfunction as a consequence of prolonged pain (74) and sexual dysfunction (69) . Although research supports both constructs (79, 80) , the direction of these relationships remains unclear, and both pathways may be operative in vestibulitis.
Differences in severity of anxiety and somatization are also observed among subgroups of women with vestibulitis (60, 81) . Women conventionally considered to have primary vestibulitis experience higher levels of anxiety and somatization and are more refractory to treatment compared with women with secondary vestibulitis (60, 81) . Longer duration and more severe pain are commonly postulated reasons for the observed psychologic differences in crosssectional or retrospective studies between primary and secondary vestibulitis.
Alternatively, some women with vestibulitis may have psychologic profiles that favor anxiety and somatization as risk factors for the development of the disorder and do not result from having the condition (although the traits may be amplified by symptoms). As outlined here, these individuals may have dysfunction in central pain-regulatory systems that promote psychologic traits that contribute to developing vestibulitis symptoms. This combination of psychologic abnormalities and pain sensitivity has been shown prospectively to be a risk factor for development of TMD among individuals who were asymptomatic at baseline (50) .
Future Directions
Our current clinical diagnostic criteria and classification of vestibulitis are inadequate for understanding the differences in underlying pathophysiological processes. Consider the challenges presented by patient scenarios as divergent as 1) a 28 year old with pain since tampon use and an unconsummated marriage; 2) a 35 year old with no history of painful intercourse until childbirth; and, 3) a 28 year old with a lifelong history of occasional pain with intercourse, which spontaneously resolved but became chronic after a severe candidal infection. As clinicians, we are acutely aware of the different challenges each of these patients present. Furthermore, based on our experience, we often empirically use different first-line therapies. However, using our current classification schema, these women, despite distinct clinical differences, are classified together as having the same disorder. We purpose a multidimensional assessment akin to our daily clinical practice, which includes detailed exploration of the patient's history and clinical examination findings before diagnosis and treatment.
In essence, the current state of diagnoses and treatment of vestibulitis may be comparable to diagnosing severe headache without a context and a conceptual model to elicit pertinent historical and physical examination, critical for differentiating sinus, migraine, cluster, or tension-type headaches. In the absence of such knowledge, a diverse range of interventions (eg, antibiotic treatment, analgesics, surgery, and acupuncture) are likely to be found effective when the "symptom" is viewed as a "disorder." Only when a symptom is examined in the context of other associ-ated signs and symptoms can we begin to decipher the differences in underlying pathophysiology.
Development of rational treatment interventions informed by the underlying pathophysiology is critically impaired in vestibulitis as a result of the lack of a conceptual model that examines the interplay between clinical variables. Reliable, reproducible, and comprehensive evaluation will be required to further advance study of vestibulitis pathophysiology, natural history, treatment efficacy, and long-term outcomes. To that end, we must: 1) objectively measure the clinical manifestation of vestibulitis as it relates to mucosal, pelvic floor muscle, psychologic, and central pain-processing mechanisms; 2) investigate the potential for distinctive subtypes; and 3) develop a conceptual framework informed by these measures to guide effective therapeutic interventions.
